The pursuit of longevity has become a prominent trend in Silicon Valley, fueled by a growing interest, particularly among the affluent, in utilizing regular testing as a means of disease prevention.

A newly launched company, Biograph, has emerged from stealth mode, co-founded by a prominent figure in the field of longevity science, Dr. Peter Attia. Dr. Attia is a Canadian-American physician, renowned for authoring the bestselling book “Outlive: The Science and Art of Longevity” and hosting a popular podcast.

John Hering, a well-known figure in Silicon Valley, serves as Biograph’s CEO and co-founder. Hering, who previously gained notoriety for scanning celebrities’ cellphones at the 2005 Academy Awards, has been a significant backer of Elon Musk’s ventures through his role as a partner at Vy Capital. He has invested billions in Musk’s startups and donated $500,000 to a pro-Trump super PAC before the election, as reported in a WSJ profile.

Biograph positions itself as the world’s most advanced preventive health and diagnostics clinic. Currently, it operates a location in Silicon Valley, with plans to expand to New York City this quarter and eventually globally, according to an announcement on its website.

The company claims to collect over 1,000 data points across 30+ evaluations to provide a comprehensive picture of an individual’s health and optimize their lifespan. However, this comprehensive approach comes at a cost, with its Core membership priced at $7,500 per year and the premium Black membership, which offers the “deepest insights,” priced at $15,000.

Biograph is backed by notable investors, including Vy Capital, Human Capital, Alpha Wave, and Wndr Co, as well as angel investors such as Balaji Srinivasan, as disclosed to TechCrunch. The company has chosen not to disclose the amount of funding it has received.

In a statement, Hering revealed that the inspiration to co-found Biograph stemmed from the cancer diagnosis of his friend and Vy Capital partner, Alexander Tamas. Tamas shared on X that an early check-up in his late 30s led to an early thyroid cancer diagnosis, likely saving his life, and encouraged Hering to undergo a check-up as well.

Biograph reports that over 15% of its members have discovered “urgent or life-altering health” insights through its services. The company has been operating quietly since 2020, as indicated by the LinkedIn profile of its executive medical director, Michael Doney, a doctor specializing in longevity.

Although Biograph’s announcement does not mention AI, the company is currently seeking a founding AI engineer to develop an AI-powered assistant, as advertised on its careers page.

Biograph is part of a growing trend of startups focused on increasing human lifespan, with companies like Andreessen Horowitz-backed Function Health seeking a $2 billion valuation this year and Sam Altman-backed Retro Biosciences in talks to raise $1 billion last month.